Medtronic Plc's Customers Performance

Name: Medtronic Plc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

MDT

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


MDT's Source of Revenues		Medtronic Plc's Corporate Customers have recorded an increase in their cost of revenue by 11.15 % in the 1 quarter 2026 year on year, sequentially costs of revenue grew by 4.2 %. During the corresponding time, Medtronic Plc recorded a revenue increase by 13.73 % year on year, sequentially revenue fell by -0.53 %. While revenue at the Medtronic Plc's corporate clients recorded rose by 7.13 % year on year, sequentially revenue grew by 4.68 %. • List of MDT Customers

Medtronic Plc's Customers have recorded an increase in their cost of revenue by 11.15 % in the 1 quarter 2026 year on year, sequentially costs of revenue grew by 4.2 %, for the same period Medtronic Plc recorded revenue increase by 13.73 % year on year, sequentially revenue fell by -0.53 %.

• List of MDT Customers

Medtronic Plc's Business Units


Total Reportable Segments	99.65 %	of total Revenue
Cardiovascular	38.34 %	of total Revenue
Cardiovascular Cardiac Rhythm Heart Failure	20.58 %	of total Revenue
Cardiovascular Structural Heart Aortic	10.3 %	of total Revenue
Cardiovascular Coronary Peripheral Vascular	7.45 %	of total Revenue
Neuroscience	28.37 %	of total Revenue
Neuroscience Cranial Spinal Technologies	14.53 %	of total Revenue
Neuroscience Specialty Therapies	8.27 %	of total Revenue
Neuroscience Neuromodulation	5.58 %	of total Revenue
Medical Surgical	24.1 %	of total Revenue
Medical Surgical Surgical Endoscopy	18.34 %	of total Revenue
Medical Surgical Acute Care Monitoring	5.76 %	of total Revenue
Diabetes	8.83 %	of total Revenue
Other segment	0.35 %	of total Revenue
U S	49.83 %	of total Revenue
International	50.17 %	of total Revenue
Reportable net sales	99.65 %	of total Revenue
Reportable net sales U S	49.63 %	of total Revenue
Reportable net sales International	50.02 %	of total Revenue
Cardiovascular U S	17.62 %	of total Revenue
Cardiovascular International	20.72 %	of total Revenue
Neuroscience U S	18.95 %	of total Revenue
Neuroscience International	9.42 %	of total Revenue
Medical Surgical U S	10.3 %	of total Revenue
Medical Surgical International	13.8 %	of total Revenue
Diabetes U S	2.75 %	of total Revenue
Diabetes International	6.08 %	of total Revenue
Other U S	0.2 %	of total Revenue
Other International	0.16 %	of total Revenue
Ireland	0.4 %	of total Revenue
Total other countries excluding Ireland	99.6 %	of total Revenue
United States	49.83 %	of total Revenue
Rest of world	49.77 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Customers Net Income grew in Q1 by	Customers Net margin grew to
57.54 %	14.09 %

Customers Net Income grew in Q1 by 57.54 %

Customers Net margin grew to 14.09 %

Medtronic Plc's Customers, Q1 2026 Revenue Growth By Industry

Customers in Healthcare Facilities Industry		6.14 %
Customers in Medical Laboratories Industry		10.21 %

• Customers Valuation

• Customers Mgmt. Effect.

Medtronic Plc's Comment on Sales, Marketing and Customers

The company serves medical specialists including electrophysiologists, implanting cardiologists, heart failure specialists, cardiovascular, cardiothoracic, and vascular surgeons, as well as interventional cardiologists and radiologists. It operates three reportable segments: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio. The Cardiovascular Portfolio includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular divisions. The Cardiac Rhythm & Heart Failure division develops and markets products for diagnosing, treating, and managing heart rhythm disorders and heart failure, including implantable cardiac pacemakers and related products. The company previously operated a Diabetes Business, which was separated into a new independent publicly traded company, MiniMed Group, Inc., following an initial public offering on March 9, 2026.

News about Medtronic Plc Contracts

Medtronic Unveils Cutting-Edge Percept RC Neurostimulator with BrainSense Technology, Revolutionizing Deep Brain Stimulation

FDA Approves Medtronic s Advanced Percept RC Neurostimulator with Exclusive BrainSense Technology: Revolutionizing Deep Brain StimulationIn a breakthrough development, the FDA has granted approval to Medtronic for its latest innovation - the Percept RC neurostimulator. Esteemed as the first and only deep brain stimulation system with sensing, directionality, and advanced programming, the Percept RC is set to revolutionize the treatment of neurological disorders. Medtronic plc, a global leader in healthcare technology, unveiled this revolutionary device on January 8, 2024.The Percept RC neurostimulator, equipped with exclusive BrainSense technology, marks a significant leap forward in the field of deep brain ...

Medtronic Plc’s Comment on Sales, Marketing and Customers

MDT's Stock Performance relative to it's Customers

MDT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Medtronic Plc	118,730.39	35,483.00	4,639.00	95,000
Quest Diagnostics Inc	26,355.28	11,278.00	1,075.00	57,000
Tenet Healthcare Corp	22,099.32	21,455.00	2,651.00	99,000
Neogenomics Inc	2,268.15	745.91	-99.21	2,500
Fresenius Medical Care Ag	13,074.46	21,982.91	1,334.22	109,698
Davita Inc	11,961.33	13,835.09	1,121.54	78,000
SUBTOTAL	417,987.16	1,263,561.83	2,143.09	1,916,396

2 more clients available

Sources: Medtronic Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 5:24 PM
Focus of this report: Medtronic Plc’s corporate clients.
For your research, we’ve provided 9 tables on Medtronic Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.